Clinical study to investigate the effects of mitiglinide add-on therapy with pioglitazone in patients with type 2 diabetes and cardiovascular disease.
Not Applicable
- Conditions
- Patients withtype 2 diabetes and cardiovascular disease or atherosclerosis-prone.
- Registration Number
- JPRN-UMIN000004480
- Lead Sponsor
- Cardioangiology, Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. acute coronary syndrome (< 3 weeks) 2. moderate to severe heart failure (BNP > 200 pg/mL) 3. SU usage in recent 3 months 4. insulin usage 5. severe diabetic retinopathy 6. mitiglinide usage 7. impossible to use mitiglinide or pioglitazone 8. impossible to evaluate precise effects of mitiglinide or pioglitazone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method